Molecular Partners AG (MOLN)

Molecular Partners AG Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	67.93	82.65	63.87	67.31	87.95	71.81
Short-Term Investments	-	10.41	85.57	119.58	161.2	61
Cash & Short-Term Investments	67.93	93.06	149.44	186.89	249.14	132.81
Cash Growth	-40.66%	-37.73%	-20.04%	-24.99%	87.59%	-23.55%
Accounts Receivable	1.34	0.25	0.29	0.3	0.52	23.71
Other Receivables	-	1.05	0.82	1.45	1	1.99
Receivables	1.34	1.3	1.11	1.75	1.53	25.7
Prepaid Expenses	-	1.91	2.25	2.49	3.91	5.65
Other Current Assets	2.16	0.6	1.48	1.34	0.17	0.02
Total Current Assets	71.43	96.88	154.28	192.46	254.75	164.19
Property, Plant & Equipment	4.27	5.23	4.2	5.68	7.24	8.15
Other Intangible Assets	-	0	0.05	0.21	0.27	0.33
Total Assets	75.7	102.11	158.53	198.35	262.26	172.67

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.77	0.94	0.68	0.41	1	4.86
Accrued Expenses	6.85	8.88	8.89	8.47	8.65	12.5
Current Portion of Leases	1.21	1.21	1.22	1.21	1.2	1.19
Current Unearned Revenue	-	-	-	4.33	6.41	28.31
Other Current Liabilities	-	-0	-	-	-	-
Total Current Liabilities	9.82	11.03	10.79	14.42	17.25	46.87
Long-Term Leases	1.83	2.44	1.23	2.44	3.65	4.85
Long-Term Unearned Revenue	-	-	-	-	3.64	6.93
Pension & Post-Retirement Benefits	5.34	8.15	4.88	5.06	2.55	6.74
Other Long-Term Liabilities	0.16	0.16	-	-	-	-
Total Liabilities	17.15	21.77	16.89	21.92	27.09	65.38

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	4.04	4.04	4.04	3.64	3.6	3.23
Additional Paid-In Capital	390.92	389.18	384.88	365.53	360.32	355.01
Retained Earnings	-335.18	-311.75	-246.29	-191.76	-127.78	-250.95
Treasury Stock	-1.23	-1.13	-0.98	-0.98	-0.98	-
Shareholders' Equity	58.54	80.33	141.64	176.43	235.17	107.29
Total Liabilities & Equity	75.7	102.11	158.53	198.35	262.26	172.67

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	3.04	3.64	2.44	3.65	4.85	6.04
Net Cash (Debt)	64.89	89.41	147	183.24	244.29	126.77
Net Cash Growth	-42.40%	-39.17%	-19.78%	-24.99%	92.70%	-23.86%
Net Cash Per Share	1.72	2.40	4.32	5.59	7.34	4.09
Filing Date Shares Outstanding	38.31	37.41	36.86	32.85	32.54	32.15
Total Common Shares Outstanding	38.31	37.41	36.86	32.85	32.54	32.15
Working Capital	61.61	85.85	143.5	178.04	237.5	117.33
Book Value Per Share	1.53	2.15	3.84	5.37	7.23	3.34
Tangible Book Value	58.54	80.33	141.59	176.22	234.9	106.96
Tangible Book Value Per Share	1.53	2.15	3.84	5.36	7.22	3.33
Machinery	-	12.44	12.21	11.77	11.69	10.66
Leasehold Improvements	-	0.63	0.63	0.63	0.62	0.61

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 28, 2026

Data Sources Report a data error